Add-on Acquisition • Life Science

CellCarta Acquires Clinical Logistics

On January 7, 2021, CellCarta acquired life science company Clinical Logistics

Acquisition Context
  • This is CellCarta’s 5th transaction in the Life Science sector.
  • This is CellCarta’s 1st transaction in Canada.
  • This is CellCarta’s 1st transaction in Nova Scotia.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 7, 2021
Target Clinical Logistics
Sector Life Science
Buyer(s) CellCarta
Deal Type Add-on Acquisition

Target Company

Clinical Logistics

Dartmouth, Nova Scotia, Canada
Clinical Logistics, Inc. is a contract research organization (CRO) providing clinical trial services to global pharmaceutical and biotech companies. The services include the provision of specimen collection supplies, production of customized specimen identification labels and kits, and specimen shipping coordination, management, and tracking. Clinical Logistics is based in Dartmouth, Nova Scotia.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

CellCarta

Montreal, Quebec, Canada

Category Company
Founded 2000
Sector Life Science
Employees700
DESCRIPTION

CellCarta is a provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. CellCarta was founded in 2000 and is based in Montreal, Quebec.


Deal Context for Buyer #
Overall 5 of 7
Sector: Life Science 5 of 7
Type: Add-on Acquisition 4 of 6
State: Nova Scotia 1 of 1
Country: Canada 1 of 1
Year: 2021 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-01 HistoGeneX

Antwerp, Belgium

HistoGeneX is a laboratory group, supports pharmaceutical and biotechnology companies in the process of developing, approving and monitoring new anticancer drugs through the development and implementation of biomarker tests. HistoGeneX was founded in 2001 and is based in Antwerp, Belgium.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-11 Reveal Biosciences

San Diego, California, United States

Reveal Biosciences is a computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. Reveal Biosciences was founded in 2012 and is based in San Diego, California.

Buy -